Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-12-11
2011-12-27
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S336000, C546S268100
Reexamination Certificate
active
08084456
ABSTRACT:
A compound of general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating a hyperproliferation-related disease state or disorder in a subject using a compound of formula (I) is also described.
REFERENCES:
patent: 7122550 (2006-10-01), Burns et al.
patent: WO-02/060492 (2002-08-01), None
patent: WO-03/031406 (2003-04-01), None
patent: WO-03/099796 (2003-12-01), None
patent: WO-2004/000318 (2003-12-01), None
patent: WO-2004/085409 (2004-10-01), None
patent: WO-2005/054199 (2005-06-01), None
Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, 205.
Dörwald, F. Zaragoza. Side Reactions in Organic Synthesis: A Guide to Successful Synthesis Design, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, 2005, Preface.
Vippagunta, et al. Advanced Drug Delivery Reviews, 48, 2001, 18.
Chawla, et al. Curr. Res. & Info. Pharm. Sci. (CRIPS), 5, 1, 2004, 9-12.
Supplementary European Search Report for EP 03778161, search completed Jul. 10, 2007, 2 pages.
Zimmermann et al., Archie der Pharmazie (1996) 329(7):371-376.
Ding et al., J. Am. Chem. Soc. (2002) 124(8):1594-1596.
International Search Report for PCT/AU2003/001661, mailed on Mar. 11, 2004, 2 pages.
Bu Xianyong
Burns Christopher John
Harte Michael Francis
Sikanyika Harrison
Wilks Andrew Frederick
Morrison & Foerster / LLP
Willis Douglas M
Wilson James O
YM Biosciences Australia Pty Ltd
LandOfFree
Pyrazine-based tubulin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazine-based tubulin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazine-based tubulin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4258497